Here, we have investigated the expression of CD155 in BC tissues and the association with pathological characteristics, immune function of tumor microenvironment, and survival, in order to explore the immunotherapy potence of the CD155 pathway among BC patients. This evidence concerns the gene PVR and breast cancer.